Four studies presented at the European Association for the Study of Diabetes meeting showed linagliptin alone or in combination with other diabetes drugs or basal insulin treatment significantly improved blood glucose levels without increasing the risk of hypoglycemia or weight gain in adults and elderly patients with type 2 diabetes. One study also showed linagliptin therapy reduced albuminuria in type 2 diabetes patients with early nephropathy.

Related Summaries